Serum leptin monitoring in anorectic patients during refeeding therapy.
Circulating concentrations of leptin are exceedingly low in severe malnutrition as seen in the acute state of anorexia nervosa (AN). During refeeding therapy plasma leptin levels increase to normal and in some cases peak at values in excess of the BMI of matched controls even before a normal body weight has been achieved. Peak leptin levels are possibly the cause of an increased energy expenditure during this stage of the disorder and might predispose to renewed weight loss (rebound phenomenon). In this study we investigated the role of leptin fluctuations as a prognostic factor of therapeutic success in AN. In 11 anorectic female patients serum leptin levels, BMI and body fat percentage were evaluated in four-week intervals during a conventional refeeding program over three months (group 1). The results of the first two measurements were used to determine a range of increases in leptin levels in relation to increases in BMI. The values between the 25th and 75th percentiles determined the reference range. In a second group of 9 anorectic female patients serum leptin levels, BMI, body fat percentage and the increase in the leptin level in relation to the BMI of each subject were investigated for three months every two weeks. These patients were also treated according to the same conventional refeeding program, but the caloric intake was reduced or increased (+/-250 kcal/d) if the increase in the leptin level, in relation to the increase in the BMI, had exceeded or fallen short of the reference range. During the refeeding therapy every subject of each group experienced increases in serum leptin levels, BMI and body fat percentage. Six subjects of group 1 and six subjects of the second group had an increase in leptin levels in relation to the increase of the BMI out of the reference range at least once. To investigate the therapeutic outcome of leptin monitoring and the following alteration of caloric intake, weight gain of the patients of both groups during the whole treatment was compared. No significant difference was found. Our results probably do not support the findings that high leptin levels predispose to a renewed loss of weight. The outcome in our patients whose caloric intake was modified due to their serum leptin levels was not significantly improved.
Lob
S
S
Max-Planck-Institute of Psychiatry, Munich, Germany. simone.lob@stud.uni-muenchen.de
Pickel
J
J
Bidlingmaier
M
M
Schaaf
L
L
Backmund
H
H
Gerlinghoff
M
M
Stalla
G K
GK
D000273:Adipose Tissue / Q000033:anatomy & histology; D000855:Anorexia / Q000097:blood* / Q000178:diet therapy*; D015415:Biomarkers / Q000097:blood; D015992:Body Mass Index; D001835:Body Weight; D002149:Energy Intake; D005215:Fasting; D005260:Female; D006801:Humans; D020738:Leptin / Q000097:blood*; D008991:Monitoring, Physiologic; D011237:Predictive Value of Tests; D011379:Prognosis; D012016:Reference Values; D013997:Time Factors; D015430:Weight Gain / Q000502:physiology
D015415:Biomarkers; D020738:Leptin